WO2015072566A1 - 超音波治療装置 - Google Patents
超音波治療装置 Download PDFInfo
- Publication number
- WO2015072566A1 WO2015072566A1 PCT/JP2014/080365 JP2014080365W WO2015072566A1 WO 2015072566 A1 WO2015072566 A1 WO 2015072566A1 JP 2014080365 W JP2014080365 W JP 2014080365W WO 2015072566 A1 WO2015072566 A1 WO 2015072566A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrasound
- therapeutic
- therapy apparatus
- treatment
- ultrasonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0883—Clinical applications for diagnosis of the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/52—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/5207—Devices using data or image processing specially adapted for diagnosis using ultrasonic, sonic or infrasonic waves involving processing of raw data to produce diagnostic data, e.g. for generating an image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/54—Control of the diagnostic device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B2017/22005—Effects, e.g. on tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0052—Ultrasound therapy using the same transducer for therapy and imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0073—Ultrasound therapy using multiple frequencies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0082—Scanning transducers
Definitions
- the present invention relates to an ultrasonic therapy apparatus.
- ischemic tissue for example, treatment for ischemic heart disease
- conventionally surgical treatment by surgery is performed.
- This treatment method is highly invasive to the patient and places a heavy burden on the patient.
- ischemic tissue using shock waves is a method of treating a myocardial tissue damaged by stenosis or occlusion of a part of the coronary artery of the heart by irradiating it with a weak shock wave.
- a shock wave is irradiated to an ischemic tissue, a therapeutic effect that promotes neovascular regeneration at the irradiated site is known.
- This treatment method is non-invasive and places little burden on the patient.
- a device described in Patent Document 1 is known. This device is an application of a stone crushing device, and irradiates the affected area with a shock wave whose output is weaker than that of the stone crushing device.
- the shock wave irradiation head is relatively large, for example, in the case of heart treatment, in addition to the myocardium to be treated, the shock wave is irradiated to tissues such as ribs and lung tissue.
- tissues such as ribs and lung tissue.
- shock waves are reflected and scattered at the boundary with living soft tissue and reach the myocardium etc. to be treated. This reduces the shock wave that occurs and increases the shock wave that reaches other than the treatment target.
- Patent Document 2 proposes an ultrasonic therapy apparatus in Patent Document 2 that minimizes ultrasonic irradiation to areas other than the treatment site.
- the present invention has been made in the course of research and development, and an object of the present invention is to provide an ultrasonic therapy apparatus having a higher therapeutic effect than before.
- a suitable ultrasonic therapy apparatus for the above purpose includes a probe for transmitting and receiving an ultrasonic wave, a transmitter for controlling the probe to scan a diagnostic ultrasonic transmission beam within a diagnostic region, and a diagnostic ultrasonic transmission beam.
- a reception unit that obtains a diagnostic ultrasound reception signal along a reception beam corresponding to the above, and an image formation unit that forms an ultrasound image of a diagnostic region based on the diagnostic ultrasound reception signal,
- the transmission unit controls the probe to form a transmission beam of therapeutic ultrasound, and scans the transmission beam of therapeutic ultrasound within a treatment region set in the diagnosis region.
- the diagnostic ultrasound has the same wave number and irradiation intensity as compared with the ultrasound used for diagnosis in the conventional ultrasound diagnostic apparatus. It is sent and received using the vibration element of the device.
- therapeutic ultrasonic waves have a higher wave number than diagnostic ultrasonic waves.
- the therapeutic ultrasound may have the same irradiation intensity as the diagnostic ultrasound, and the therapeutic ultrasound can be transmitted using a vibration element that transmits and receives the diagnostic ultrasound.
- a vibration element that transmits and receives diagnostic ultrasonic waves and a vibration element that transmits therapeutic ultrasonic waves may be provided separately.
- the therapeutic ultrasonic wave having a higher wave number than the diagnostic ultrasonic wave is used, the therapeutic effect is enhanced as compared with the case of using the therapeutic ultrasonic wave having the same wave number as the diagnostic ultrasonic wave.
- the wave number of diagnostic ultrasound is about 1 wave or 2 waves
- the wave number of therapeutic ultrasound is 3 or more.
- the wave number of the therapeutic ultrasonic wave is preferably about 6 waves or more, for example, selected from 16 waves, 32 waves, 48 waves, 64 waves, and the like. From the experimental results, the highest therapeutic effect is expected to be 32 waves. Therefore, it is particularly desirable that the wave number of therapeutic ultrasonic waves be 32 waves.
- the wave number of the therapeutic ultrasound wave is not limited to 32 waves, and may be set to a wave number similar to 32 waves.
- the wave number comparable to 32 waves is, for example, 16 waves to 48 waves, preferably 24 waves to 40 waves, but is not limited to these examples.
- the transmission beam of therapeutic ultrasound is scanned within the treatment area, the therapeutic effect is enhanced as compared with the case where the transmission beam of therapeutic ultrasound is not scanned.
- a scanning mode of the transmission beam of therapeutic ultrasonic waves in addition to continuous scanning that shifts the angle and position of the transmission beam line by line, the angle of the transmission beam across multiple lines regularly or irregularly, Also included are discrete scans that change position.
- treatment ultrasound having a higher wave number than diagnostic ultrasound is irradiated, an improvement is seen in the treatment site (eg, ischemic tissue), but significant in the normal site (eg, normal tissue). Does not have a significant impact.
- ultrasonic waves for treatment are transmitted over the entire treatment area to suppress the influence on the normal area and over the entire treatment area.
- scanning the therapeutic ultrasound transmission beam in the treatment area a wide range of treatment is possible and the treatment effect of the entire treatment area is enhanced as compared with the case where scanning is not performed.
- the transmitting unit controls the probe so as to transmit a therapeutic ultrasonic wave having a wave number of 32 waves.
- the ultrasonic therapy apparatus includes a diagnostic mode that uses diagnostic ultrasonic waves and a therapeutic mode that uses therapeutic ultrasonic waves.
- the transmission unit transmits therapeutic ultrasonic waves.
- the beam is scanned in the treatment area
- the reception unit acquires a reception signal of the treatment ultrasonic wave from the treatment area along the reception beam corresponding to the transmission beam of the treatment ultrasonic wave
- the image forming unit is An ultrasonic image of a treatment area is formed based on a reception signal of therapeutic ultrasonic waves.
- the ultrasonic therapy apparatus includes a diagnostic mode that uses diagnostic ultrasonic waves and a therapeutic mode that uses therapeutic ultrasonic waves.
- the transmission unit emits therapeutic ultrasonic waves.
- the treatment ultrasonic wave is scanned within the treatment area so that the pressure periodically fluctuates, and the treatment site is swung by the fluctuating radiation pressure.
- an ultrasonic therapy apparatus having a higher therapeutic effect than before is provided.
- therapeutic ultrasonic waves having a higher wave number than diagnostic ultrasonic waves are used, so that compared with the case where therapeutic ultrasonic waves having the same wave number as diagnostic ultrasonic waves are used.
- the therapeutic effect increases.
- the therapeutic ultrasound transmission beam is scanned within the treatment area, so that the therapeutic effect is enhanced as compared with the case where the therapeutic ultrasound transmission beam is not scanned.
- FIG. 1 is a diagram showing an overall configuration of an ultrasonic treatment apparatus suitable for implementation of the present invention. It is a figure which shows the specific example of a diagnostic ultrasound and a therapeutic ultrasound. It is a figure which shows the experimental result which concerns on expression of an angiogenic factor. It is a figure which shows the experimental result regarding the influence which the ultrasonic wave for treatment has on a structure
- 3 is a flowchart showing an operation example of the ultrasonic therapy apparatus of FIG. 1.
- FIG. 1 is an overall configuration diagram of an ultrasonic therapy apparatus 100 suitable for implementation of the present invention.
- the ultrasonic therapy apparatus 100 is suitable for treating ischemic tissue, for example, and an example of a suitable treatment target is the heart.
- the treatment target of the ultrasonic therapy apparatus 100 is not limited to the heart, and for example, a blood vessel or an organ other than the heart may be the treatment target.
- the ultrasonic therapy apparatus 100 uses diagnostic ultrasonic waves and therapeutic ultrasonic waves.
- the probe 10 includes a plurality of vibration elements (not shown) that transmit and receive diagnostic ultrasonic waves and therapeutic ultrasonic waves.
- the plurality of vibration elements may be any of element arrays corresponding to, for example, a convex scanning type, a sector scanning type, a linear scanning type, a two-dimensional image (tomographic image), or a three-dimensional image.
- each of the plurality of vibration elements included in the probe 10 can transmit and receive both diagnostic and therapeutic ultrasonic waves, the vibration element that transmits and receives diagnostic ultrasonic waves and the vibration that transmits and receives therapeutic ultrasonic waves. Elements may be provided separately.
- the transmission unit 12 controls the probe 10 by outputting transmission signals to a plurality of vibration elements included in the probe 10.
- the transmission unit 12 controls the probe 10 to scan the diagnostic ultrasound transmission beam within the diagnostic region. Further, the transmission unit 12 controls the probe 10 to scan the therapeutic ultrasound transmission beam within the treatment region. That is, the transmission unit 12 has a transmission beamformer function. Specific scanning processing by the transmission unit 12 will be described in detail later.
- the reception unit 14 forms a reception beam by performing phasing addition processing on a plurality of reception signals obtained from a plurality of vibration elements included in the probe 10, and obtains a reception signal along the reception beam. That is, the receiving unit 14 has a reception beamformer function.
- the reception unit 14 forms a reception beam corresponding to the transmission beam of the diagnostic ultrasonic wave and obtains a diagnostic ultrasonic signal from the diagnostic region.
- the receiving unit 14 forms a reception beam corresponding to the transmission beam of the therapeutic ultrasonic wave and obtains a reception signal of the therapeutic ultrasonic wave from the treatment area.
- the image forming unit 20 forms an ultrasonic image of the diagnostic region based on the diagnostic ultrasonic reception signal.
- the image forming unit 20 forms an ultrasonic image of the treatment area based on the reception signal of the therapeutic ultrasonic wave.
- a preferred specific example of the ultrasonic image is a B-mode image obtained by a known B-mode image forming process. Note that the image forming unit 20 may form a three-dimensional ultrasonic image, a color Doppler image, or the like as the ultrasonic image.
- the ultrasonic image formed in the image forming unit 20 is displayed on the display unit 30.
- the control unit 40 controls the inside of the ultrasonic therapy apparatus 100 intensively.
- the operation device 50 is a device that receives an operation from the user, and an instruction received from the user by the operation device 50 is sent to the control unit 40 and reflected in the control in the ultrasonic therapy apparatus 100.
- the transmission unit 12, the reception unit 14, and the image forming unit 20 are each realized by using hardware such as a processor and an electronic circuit, for example.
- a suitable specific example of the display unit 30 is, for example, a liquid crystal display.
- the operation device 50 is configured by at least a part of, for example, a mouse, a trackball, a keyboard, a touch panel, and other switches.
- the control unit 40 is configured by hardware such as a CPU having an arithmetic function, for example, and the function of the control unit 40 is realized by cooperation of the hardware and software (program) that defines the operation thereof. .
- the overall configuration of the ultrasonic therapy apparatus 100 is as described above. Next, functions and the like realized by the ultrasonic therapy apparatus 100 will be described in detail. In addition, about the structure (part) shown in FIG. 1, the code
- FIG. 2 is a diagram showing specific examples of diagnostic ultrasound and therapeutic ultrasound.
- FIG. 2 shows waveforms of diagnostic ultrasound and therapeutic ultrasound transmitted in the ultrasound treatment apparatus 100 of FIG.
- the ultrasonic wave for diagnosis has the same wave number and irradiation intensity as compared with the ultrasonic wave used for the diagnosis of a conventionally known general ultrasonic diagnostic apparatus.
- the ultrasonic waves used for diagnosis in a general ultrasonic diagnostic apparatus are usually about 1 wave to 2 waves. Therefore, in the ultrasonic therapy apparatus 100 of FIG. 1, the wave number of the diagnostic ultrasonic wave is, for example, about 1 wave to 2 waves.
- FIG. 2 ⁇ A> shows a wave number 1 (one wave) as a specific example of diagnostic ultrasound. For example, a waveform of about 2 to 6 waves may be used as the diagnostic ultrasound.
- therapeutic ultrasonic waves are long burst waves having a higher wave number than diagnostic ultrasonic waves.
- the wave number of the therapeutic ultrasonic wave is desirably about 6 waves or more, and specifically, for example, selected from 16 waves, 32 waves, 48 waves, 64 waves, and the like.
- FIG. 2 ⁇ B> shows a wave number 16 (16 waves) as a specific example of therapeutic ultrasound
- FIG. 2 ⁇ C> shows a wave number 32 as a specific example of therapeutic ultrasound.
- a waveform of (32 waves) is shown
- a waveform of wave number 64 (64 waves) is shown as a specific example of therapeutic ultrasonic waves.
- FIG. 3 is a diagram showing experimental results relating to the expression of angiogenic factors.
- FIG. 3 shows angiogenic factors (VEGF) when the wave number of therapeutic ultrasound is 1 (1 Cycle), 16 (16 Cycle), 32 (32 Cycle), 48 (48 Cycle), and 64 (64 Cycle). ) Expression (vertical axis) is shown, with the highest expression at 32 waves. That is, according to this experimental result, the therapeutic effect of ischemic tissue is the highest when the wave number of therapeutic ultrasonic waves is 32 waves. Therefore, in the ultrasonic therapy apparatus 100 of FIG. 1, for example, therapeutic ultrasonic waves having a wave number of 32 waves are used.
- VEGF angiogenic factors
- FIG. 4 is a diagram showing experimental results regarding the effect of therapeutic ultrasound on the tissue.
- FIG. 4 ⁇ A> shows the experimental results related to the expression of angiogenic factor (VEGF)
- FIG. 4 ⁇ B> shows the experimental results related to the expression of endothelial nitric oxide synthase (eNOS)
- FIG. > Shows the experimental results relating to the expression of basic fibroblast growth factor (bFGF).
- FIG. 4 ⁇ A> to ⁇ C> show the expression levels of the respective factors when the therapeutic ultrasound is transmitted for each of the ischemic tissue and the normal tissue.
- FIG. 5 is a diagram showing experimental results relating to capillary density.
- FIG. 5 shows capillary density when therapeutic ultrasonic waves are transmitted for each of the ischemic tissue and the normal tissue. As shown in FIG. 5, by transmitting therapeutic ultrasonic waves, the capillary density is increased for ischemic tissue, but the increase in capillary density is suppressed for normal tissue. That is, due to therapeutic ultrasound, the capillary density is increased only at the ischemic site.
- the ultrasonic treatment apparatus 100 in FIG. 1 transmits therapeutic ultrasonic waves over the entire treatment region even when a treatment site (ischemic tissue) and a normal site (normal tissue) are mixed in the treatment region.
- ischemic tissue ischemic tissue
- normal site normal tissue
- FIG. 6 is a view showing a specific example of scanning of therapeutic ultrasound.
- FIG. 6 shows a specific example when treating ischemic tissue in the myocardium of the heart.
- FIG. 6 shows a display image 32 displayed on the display unit 30.
- the display image 32 includes an ultrasound image of a diagnostic region including the heart, that is, a B-mode image (short axis image) of the short axis of the heart.
- the B-mode image of the short heart axis is formed by a known B-mode image forming process via diagnostic ultrasound. That is, the transmission unit 12 scans the diagnostic ultrasound transmission beam in the diagnostic region, and the reception unit 14 collects the reception signal from the diagnostic region along the reception beam corresponding to the transmission beam. Based on this, the image forming unit 20 forms a B-mode image of the diagnostic area.
- the treatment region is set so as to include the myocardial ischemic tissue that is the treatment site.
- the angle ⁇ 1 of the right boundary line and the angle ⁇ 2 of the left boundary line are set in the diagnosis region, and the region between the set right boundary line and the left boundary line becomes the treatment region.
- a user (therapist such as a doctor) of the ultrasonic treatment apparatus 100 operates the operation device 50 such as a trackball while viewing the display image 32 that displays a short-axis image of the heart, and ischemic tissue to be treated. Is adjusted to adjust the angle ⁇ 1 of the right boundary line and the angle ⁇ 2 of the left boundary line to set the treatment region within the diagnosis region.
- the transmission unit 12 scans the treatment ultrasound transmission beam within the treatment area, and ischemic tissue is treated.
- the transmitter 12 corresponds to the left boundary line in the order of the lines 1, 2, 3, 4,. Scan to line n.
- the transmission unit 12 may perform scanning that shifts the transmission beam line across a plurality of lines regularly or irregularly, instead of scanning that shifts the transmission beam line by line.
- the focus (depth of focus) of the transmission beam of therapeutic ultrasound is set to a depth at which ischemic tissue exists.
- the user operates the operation device 50 while viewing the display image 32 to set the focus depth of the therapeutic ultrasound.
- the treatment range of the treatment region may be the same as the diagnosis range of the diagnosis region (pulse repetition cycle of diagnostic ultrasound).
- the treatment range of the treatment area may be adjusted according to the focus depth.
- the transmitter 12 scans the therapeutic ultrasound transmission beam within the treatment region so that the radiation pressure of the therapeutic ultrasound periodically varies, and swings the treatment site with the varying radiation pressure.
- the therapeutic effect is further increased by transmitting therapeutic ultrasonic waves while swinging the treatment site.
- the range in which the tissue vibrates is determined by the ultrasonic repetition frequency and the speed of the transverse wave. Since the velocity of the transverse wave in the living body is about 1 to 10 m / sec, for example, if the velocity of the transverse wave is 1 m / sec, if the ultrasonic wave is repeatedly transmitted at a cycle of 100 Hz, the ultrasonic focus point A range with a length of about 10 mm in the vicinity vibrates more effectively.
- FIG. 6 shows a specific example of a therapeutic ultrasound transmission sequence suitable for vibration caused by radiation force.
- the transmission beam of therapeutic ultrasound is scanned from line 1 to line n in the order of lines 2, 3, 4,.
- PRF pulse repetition frequency
- the number of beams n is 100
- the period of irradiation of therapeutic ultrasonic waves to the same tissue site is 100 Hz, and the tissue site is effectively vibrated.
- the treatment site may be vibrated by radiation ultrasonic waves that generate radiation force instead of treatment ultrasonic waves.
- FIG. 7 is a flowchart showing an example of treatment by the ultrasonic treatment apparatus of FIG.
- a diagnostic mode using diagnostic ultrasound is executed before a therapeutic mode using therapeutic ultrasound. That is, transmission / reception of diagnostic ultrasound is started (S601), and an ultrasound image of a diagnostic region relating to the subject including the treatment site is displayed (S602).
- a user (therapist such as a doctor) of the ultrasonic therapy apparatus 100 moves the probe 10 as necessary while viewing an ultrasonic image (for example, a short-axis image of the heart shown in FIG. 6) displayed on the display unit 30. It is moved by hand to search for a treatment site in the subject (S603). When the treatment site is searched, the user operates the operation device 50 so that the treatment site displayed in the ultrasonic image is included, and the treatment region (for example, the angle ⁇ 1 and the angle ⁇ 2 illustrated in FIG. ) Is set (S604).
- an ultrasonic image for example, a short-axis image of the heart shown in FIG. 6
- the user operates the operation device 50 so that the treatment site displayed in the ultrasonic image is included, and the treatment region (for example, the angle ⁇ 1 and the angle ⁇ 2 illustrated in FIG. ) Is set (S604).
- the ultrasonic image is a three-dimensional image
- a two-dimensional treatment region (angle ⁇ 1 and angle ⁇ 2) is set in an arbitrary two-dimensional plane, and further intersects the two-dimensional plane (for example, orthogonal)
- a two-dimensional treatment region (angle ⁇ 3 and angle ⁇ 4) may be set in a two-dimensional plane, and a three-dimensional stereoscopic treatment region may be set based on these two two-dimensional treatment regions.
- the method of setting a three-dimensional treatment region is not limited to the above specific example.
- the user sets the focus depth for the transmission beam of the therapeutic ultrasonic wave so that the therapeutic ultrasonic wave is effectively transmitted to the treatment site, and the therapeutic ultrasonic wave is transmitted.
- the treatment range of the area is set (S605).
- the ultrasonic treatment apparatus 100 is switched from the diagnostic mode to the treatment mode (S606), the transmission of the therapeutic ultrasonic wave is started, and the transmission beam of the therapeutic ultrasonic wave is scanned in the treatment region.
- step S607 treatment with therapeutic ultrasound is performed.
- the probe 10 may be fixed with a jig or the like at any timing after the treatment site search (S603) is performed and before the transmission of therapeutic ultrasound waves is started (S607). desirable.
- the receiving unit 14 forms a reception beam corresponding to the therapeutic ultrasound transmission beam to form the treatment ultrasound area.
- the image forming unit 20 forms an ultrasonic image (for example, a B-mode image) of the treatment region based on the reception signal of the therapeutic ultrasonic wave, and the formed ultrasonic image is displayed on the display unit 30 (S608). ).
- the user can confirm the treatment status from the ultrasound image of the treatment area. The user can confirm, for example, whether therapeutic ultrasound is transmitted to the treatment area.
- the transmission of therapeutic ultrasonic waves is completed (S609), and the treatment for the treatment region is completed. If it is necessary to set a plurality of treatment regions in the subject, for example, the flowchart of FIG. 7 is executed for each treatment region.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Cardiology (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims (13)
- 超音波を送受するプローブと、
プローブを制御して診断用超音波の送信ビームを診断領域内で走査する送信部と、
診断用超音波の送信ビームに対応した受信ビームに沿って診断用超音波の受信信号を得る受信部と、
診断用超音波の受信信号に基づいて診断領域の超音波画像を形成する画像形成部と、
を有し、
前記送信部は、プローブを制御することにより、治療用超音波の送信ビームを形成し、診断領域内に設定される治療領域内で治療用超音波の送信ビームを走査する、
ことを特徴とする超音波治療装置。 - 請求項1に記載の超音波治療装置において、
前記送信部は、診断用超音波よりも波数の多い治療用超音波の送信ビームを形成し、診断領域内に設定される治療領域内で治療用超音波の送信ビームを走査する、
ことを特徴とする超音波治療装置。 - 請求項1に記載の超音波治療装置において、
前記送信部は、波数が6波~64波の治療用超音波を送波するようにプローブを制御する、
ことを特徴とする超音波治療装置。 - 請求項2に記載の超音波治療装置において、
前記送信部は、波数が6波~64波の治療用超音波を送波するようにプローブを制御する、
ことを特徴とする超音波治療装置。 - 請求項3に記載の超音波治療装置において、
前記送信部は、虚血組織を含む治療領域内で治療用超音波の送信ビームを走査する、
ことを特徴とする超音波治療装置。 - 請求項4に記載の超音波治療装置において、
前記送信部は、虚血組織を含む治療領域内で治療用超音波の送信ビームを走査する、
ことを特徴とする超音波治療装置。 - 請求項5に記載の超音波治療装置において、
前記送信部は、治療用超音波の送信ビームの焦点を虚血組織の深さに設定する、
ことを特徴とする超音波治療装置。 - 請求項6に記載の超音波治療装置において、
前記送信部は、治療用超音波の送信ビームの焦点を虚血組織の深さに設定する、
ことを特徴とする超音波治療装置。 - 請求項1に記載の超音波治療装置において、
診断用超音波を利用する診断モードと治療用超音波を利用する治療モードとを備え、
治療モードにおいて、
前記送信部は、治療用超音波の送信ビームを治療領域内で走査し、
前記受信部は、治療用超音波の送信ビームに対応した受信ビームに沿って治療領域内から治療用超音波の受信信号を取得し、
前記画像形成部は、治療用超音波の受信信号に基づいて治療領域の超音波画像を形成する、
ことを特徴とする超音波治療装置。 - 請求項9に記載の超音波治療装置において、
前記送信部は、治療モードにおいて、虚血組織を含む治療領域内で治療用超音波の送信ビームを走査する、
ことを特徴とする超音波治療装置。 - 請求項10に記載の超音波治療装置において、
前記送信部は、治療モードにおいて、治療用超音波の送信ビームの焦点を虚血組織の深さに設定する、
ことを特徴とする超音波治療装置。 - 請求項1に記載の超音波治療装置において、
診断用超音波を利用する診断モードと治療用超音波を利用する治療モードとを備え、
治療モードにおいて、
前記送信部は、治療用超音波の放射圧が周期的に変動するように、治療用超音波の送信ビームを治療領域内で走査し、変動する放射圧で治療部位を揺動させる、
ことを特徴とする超音波治療装置。 - 請求項12に記載の超音波治療装置において、
前記送信部は、治療モードにおいて、治療用超音波の放射圧が周期的に変動するように治療用超音波の送信ビームを治療領域内で走査し、変動する放射圧で治療部位である虚血組織を揺動させる、
ことを特徴とする超音波治療装置。
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/037,111 US11083914B2 (en) | 2013-11-18 | 2014-11-17 | Ultrasonic treatment device |
| JP2015547815A JP6653172B2 (ja) | 2013-11-18 | 2014-11-17 | 超音波治療装置 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013237707 | 2013-11-18 | ||
| JP2013-237707 | 2013-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2015072566A1 true WO2015072566A1 (ja) | 2015-05-21 |
Family
ID=53057498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2014/080365 Ceased WO2015072566A1 (ja) | 2013-11-18 | 2014-11-17 | 超音波治療装置 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US11083914B2 (ja) |
| JP (1) | JP6653172B2 (ja) |
| WO (1) | WO2015072566A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016101274A (ja) * | 2014-11-27 | 2016-06-02 | テルモ株式会社 | 医療用システム |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102716481B1 (ko) * | 2023-09-20 | 2024-10-14 | 주식회사 제이시스메디칼 | 초음파 영상 모니터링 장치, 방법, 프로그램 및 시스템 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07231893A (ja) * | 1994-02-22 | 1995-09-05 | Toshiba Corp | 衝撃波治療装置および超音波治療装置 |
| US20060241522A1 (en) * | 2003-06-18 | 2006-10-26 | Chandraratna Premindra A | Ultrasound devices and methods for treating ischemia and other cardiovascular disorders |
| WO2012077219A1 (ja) * | 2010-12-09 | 2012-06-14 | 日立アロカメディカル株式会社 | 超音波治療装置及びその制御方法 |
| JP2013055984A (ja) * | 2011-09-07 | 2013-03-28 | Hitachi Aloka Medical Ltd | 超音波診断装置および超音波診断用プログラム |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6247358A (ja) | 1985-08-28 | 1987-03-02 | アロカ株式会社 | 超音波刺激装置 |
| DE3835318C1 (ja) | 1988-10-17 | 1990-06-28 | Storz Medical Ag, Kreuzlingen, Ch | |
| JP2005304918A (ja) | 2004-04-23 | 2005-11-04 | Teijin Pharma Ltd | 創傷治療装置 |
| JP5603572B2 (ja) | 2009-07-07 | 2014-10-08 | 日立アロカメディカル株式会社 | 超音波治療装置 |
-
2014
- 2014-11-17 WO PCT/JP2014/080365 patent/WO2015072566A1/ja not_active Ceased
- 2014-11-17 JP JP2015547815A patent/JP6653172B2/ja active Active
- 2014-11-17 US US15/037,111 patent/US11083914B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07231893A (ja) * | 1994-02-22 | 1995-09-05 | Toshiba Corp | 衝撃波治療装置および超音波治療装置 |
| US20060241522A1 (en) * | 2003-06-18 | 2006-10-26 | Chandraratna Premindra A | Ultrasound devices and methods for treating ischemia and other cardiovascular disorders |
| WO2012077219A1 (ja) * | 2010-12-09 | 2012-06-14 | 日立アロカメディカル株式会社 | 超音波治療装置及びその制御方法 |
| JP2013055984A (ja) * | 2011-09-07 | 2013-03-28 | Hitachi Aloka Medical Ltd | 超音波診断装置および超音波診断用プログラム |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016101274A (ja) * | 2014-11-27 | 2016-06-02 | テルモ株式会社 | 医療用システム |
Also Published As
| Publication number | Publication date |
|---|---|
| US20160296767A1 (en) | 2016-10-13 |
| JPWO2015072566A1 (ja) | 2017-03-16 |
| US11083914B2 (en) | 2021-08-10 |
| JP6653172B2 (ja) | 2020-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5603572B2 (ja) | 超音波治療装置 | |
| JP7363636B2 (ja) | 超音波診断装置、及び超音波診断装置の制御方法 | |
| EP2649953B1 (en) | Ultrasound treatment device | |
| JP5231822B2 (ja) | 超音波診断装置、及び超音波診断装置の制御プログラム | |
| KR102111453B1 (ko) | 체외 충격파 치료 장치 | |
| JP2007144183A (ja) | 造影剤を用いた超音波造影及び治療装置 | |
| JP6114663B2 (ja) | 超音波診断装置および超音波画像生成方法 | |
| JP2003093389A (ja) | 超音波診断装置 | |
| JP6633314B2 (ja) | 超音波医用装置 | |
| JP7137682B1 (ja) | 超音波治療装置 | |
| JP6653172B2 (ja) | 超音波治療装置 | |
| JP2022029165A (ja) | 超音波評価装置及び超音波評価方法 | |
| JP7170359B1 (ja) | 超音波画像処理装置 | |
| JP7713245B2 (ja) | 超音波治療装置 | |
| JP7576367B1 (ja) | Hifu照射装置 | |
| JP4557261B2 (ja) | 超音波治療装置 | |
| JP2015156885A (ja) | 超音波治療システム |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14862381 Country of ref document: EP Kind code of ref document: A1 |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| ENP | Entry into the national phase |
Ref document number: 2015547815 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 15037111 Country of ref document: US |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14862381 Country of ref document: EP Kind code of ref document: A1 |